This narrative review summarizes FLNC molecular biology, genotype-phenotype relationships, imaging features, arrhythmic risk, and implications for clinical management and discusses the limited evidence linking FLNCtv to arrhythmogenic mitral valve prolapse with mitral annular disjunction.
Abstract
Variants in the filamin C (FLNC) gene are increasingly recognized as causes of cardiac and skeletal muscle disease. Cardiomyopathy-associated FLNC variants span dilated cardiomyopathy (DCM), nondilated left ventricular cardiomyopathy (NDLVC), arrhythmogenic cardiomyopathy (ACM), hypertrophic cardiomyopathy (HCM), and restrictive cardiomyopathy (RCM), but their clinical interpretation depends strongly on variant class and evidence of pathogenicity. FLNC truncating variants (FLNCtv), including nonsense, frameshift, and canonical splice-site variants, usually cause haploinsufficiency through nonsense-mediated decay and are predominantly associated with DCM/NDLVC and left-dominant ACM. These phenotypes frequently show subepicardial or circumferential ring-like fibrosis and clinically important ventricular arrhythmias that may occur despite only mild left ventricular dysfunction. On the other hand, selected pathogenic missense variants, particularly within the actin-binding domain or ROD2 immunoglobulin-like repeats 18–21, may promote protein misfolding and aggregation and have been associated with HCM or RCM, including the distinctive saw-tooth myocardial phenotype. However, most reported FLNC missense variants remain variants of uncertain significance and must not be considered disease-causing on the basis of location alone. This narrative review summarizes FLNC molecular biology, genotype-phenotype relationships, imaging features, arrhythmic risk, and implications for clinical management. It also discusses the limited evidence linking FLNCtv to arrhythmogenic mitral valve prolapse with mitral annular disjunction. Accurate variant classification and phenotype integration are essential for diagnosis and for individualized prevention of sudden cardiac death (SCD).
Findings reinforce the concept of HCM as a spectrum of diseases rather than a single genetic entity, setting the stage for more individualised approaches to diagnosis, counselling and management.
Clara Saldarriaga· Cardiac failure review· 0 citations
Background: Pathologic variants in TNNC1 are associated with the development of hypertrophic cardiomyopathy (HCM). Unlike other sarcomeric genes, TNNC1 variants tend to cause early onset disease, and the most common variant identified in the gene, TNNC1-A8V, may also lead to severe diastolic dysfunction and restrictive...
Paula F. Nieto Morales, Enya R. Dewars, Amanda M. Mascarenhas et al.· Circulation Genomic and Prec...· 0 citations
BACKGROUND
Pathogenic and likely pathogenic variants in filamin C (FLNC) cause a broad spectrum of cardiomyopathies. However, available genotype-phenotype data are derived predominantly from European and North American populations, with limited representation of admixed populations.
METHODS
We characterized carriers...
N. Olivetti, Luciana Sacilotto, Julia de Barros Negri Ferreira et al.· Circulation Genomic and Prec...· 0 citations
BACKGROUND
Pathogenic variants in lysosome-associated membrane protein 2 (LAMP2) gene cause X-linked Danon disease, associated with hypertrophic cardiomyopathy. Arrhythmogenic cardiomyopathy is characterized by myocardial fibrofatty replacement and ventricular arrhythmias.
CASE SUMMARY
A 30-year-old woman presented w...
Natália Quintella Sangiorgi Olivetti, Giovana Pereira Belitardo, Felipe Cerqueira Matheus et al.· JACC Case Reports· 0 citations
It is demonstrated that MAP3K7 variants can cause apparently isolated DCM, expanding the phenotypic spectrum of MAP3K7-related disorders, and establishing an association between MAP3K7 loss of function variants and DCM.
K. Josephs, C. Smith-Díaz, A. Woods et al.· medRxiv· 0 citations
Unsupervised and supervised machine learning approaches distinguished HCM from dilated cardiomyopathy and accurately predicted genotype status in early-stage HCM from cell type-resolved transcriptional profiles, revealing widespread genotype-driven remodeling.
E. Adami, Yuri Kim, Sean L. Zheng et al.· Science Translational Medici...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.